We provide integrated market access services which span the product development and commercialisation lifecycle
- Market access opportunity assessment
- Global and national market access strategy
- Product positioning
- Pricing and reimbursement strategy
- Launch sequencing
- Landscape and feasibility assessments
- Evidence gap analysis & generation plans
- Advisory boards
- Evidence generation planning and strategy
- Systematic literature reviews
- Rapid, scoping, umbrella & narrative reviews
- Clinical efficacy & real-world effectiveness
- Cost-of-illness & economic evaluations
- Health-related quality of life
- Epidemiology & treatment guidelines
- ITC & NMA feasibility
- Model strategy and design
- Model testing and validation
- Cost-effectiveness models
- Budget impact models
- Disease and natural history models
- Complex simulation models
- National and local model review and adaptation
- End-to-end strategic consultancy
- Stakeholder and early engagement
- Dossier development and submission
- Post-submission support
- National and local adaptations
- Advisory boards and expert validation
- Expert opinion elicitation
- Early access to medicines schemes
- Patient level & patient subgroup analyses
- Protocol development
- Statistical analysis plans
- Predictive analysis using
AI & machine learning - Indirect and mixed treatment comparisons
- Generation of health state utility values
- Novel statistical methods
- Medical record reviews
- Global value dossiers
- Value story development & slide decks
- Interactive communication tools
- Objection handlers & payer negotiation
- Data visualisation
- Publications, leave pieces and white papers
- Training and workshops
- Stakeholder engagement